In the particular case of lung cancer, SOX4 was found to be overexpressed partially due to genetic amplification of the SOX4 locus [8], and increased expression of SOX4 was identified as a potential biomarker for tumor malignancy and poor prognosis in patients with NSCLC [9]. Here, SOX4 is linked to lung cancer.